Figure 3From: Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis Kaplan-Meier plot showing time to first tumour progression by nintedanib dosing schedule. The shaded areas represent 95% confidence intervals. Abbreviations: BID = twice-daily, QD = once-daily.Back to article page